GRDN
Guardian Pharmacy·NYSE
--
--(--)
--
--(--)
8.71 / 10
Outperform
Analyst sentiment is strongly bullish: two analysts rate GRDN Strong Buy/Buy, with historical win rates of 60% and 100%. Fund flow scores 7.64, showing overall positive inflows except a slight negative trend in large‑size trades. Capital and opinion both favor upside.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-12
InstitutionTruist Securities
Times predicted5
Historical Win Rate60.0%
What is the analyst consensus for GRDN?
- GRDN holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.71/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
